医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2013年
25期
195-195
,共1页
利培酮%丙戊酸钠%精神分裂症%冲动和攻击行为
利培酮%丙戊痠鈉%精神分裂癥%遲動和攻擊行為
리배동%병무산납%정신분렬증%충동화공격행위
Risperidone%Valproic acid sodium%Schizophrenia%Impulsive and aggressive behavior
目的:探讨利培酮联合丙戊酸治疗伴有冲动和攻击行为的男性精神分裂症患者的疗效和安全性。方法对74例伴有冲动和攻击行为的男性精神分裂症患者随机分成研究组(利培酮联合丙戊酸钠治疗)37例,对照组(单用利培酮治疗)37例,疗程6w。结果两组在治疗后PANSS评分及MOAS评分均较治疗前显著下降(均P<0.05),研究组PANSS总分、阳性症状分及MOAS总分较对照组下降显著(P<0.05);两组不良反应相当,无统计学差异(P>0.05)。结论利培酮联合丙戊酸治疗伴有冲动和攻击行为的男性精神分裂症患者起效快,可增加疗效,安全性好。
目的:探討利培酮聯閤丙戊痠治療伴有遲動和攻擊行為的男性精神分裂癥患者的療效和安全性。方法對74例伴有遲動和攻擊行為的男性精神分裂癥患者隨機分成研究組(利培酮聯閤丙戊痠鈉治療)37例,對照組(單用利培酮治療)37例,療程6w。結果兩組在治療後PANSS評分及MOAS評分均較治療前顯著下降(均P<0.05),研究組PANSS總分、暘性癥狀分及MOAS總分較對照組下降顯著(P<0.05);兩組不良反應相噹,無統計學差異(P>0.05)。結論利培酮聯閤丙戊痠治療伴有遲動和攻擊行為的男性精神分裂癥患者起效快,可增加療效,安全性好。
목적:탐토리배동연합병무산치료반유충동화공격행위적남성정신분렬증환자적료효화안전성。방법대74례반유충동화공격행위적남성정신분렬증환자수궤분성연구조(리배동연합병무산납치료)37례,대조조(단용리배동치료)37례,료정6w。결과량조재치료후PANSS평분급MOAS평분균교치료전현저하강(균P<0.05),연구조PANSS총분、양성증상분급MOAS총분교대조조하강현저(P<0.05);량조불량반응상당,무통계학차이(P>0.05)。결론리배동연합병무산치료반유충동화공격행위적남성정신분렬증환자기효쾌,가증가료효,안전성호。
Objective to study the risperidone with valproic acid therapy with impulse and at ack the ef icacy and safety of male patients with schizophrenia. Methods:74cases with impulse and aggressive behavior of male schizophrenia patients were randomly divided into research group (risperidone combined valproate treatment)37cases,control group (risperidone therapy)37 cases, course of six weeks. Results:two groups after treatment PANSS scores and MOAS score was a significant reduction in the (al P<0.05),the team PANSS score,positive symptom and total scores of MOAS down significantly compared with control group (P<0.05);Two groups of adverse reactions, no statistical dif erence(P>0. 05) conclusion:risperidone with valproic acid therapy with impulse and aggressive behavior of male schizophrenia patients work fast,can increase the curative ef ect,good safety.